Publications Database

Abanilla P. K. et al. (2005)

The use of psychostimulants in pervasive developmental disorders.

Psychiatric Quarterly

76(3), pp. 271-281

Read Abstract (New Window)

Accordino R. E. et al. (2016)

Psychopharmacological interventions in autism spectrum disorder.

Expert Opinion on Pharmacotherapy

May, 17(7), pp. 937-952.

Read Abstract (New Window)

Akyol Ardic Ü. et al. (2017)

Altered response with methylphenidate to ADHD-like symptoms in pervasive developmental disorder: does CES-1 enzyme gene polymorphism have a role

European Child and Adolescent Psychiatry

Summer, 28(2), pp. 89-94.

Read Abstract (New Window) Read Full (New Window)

Aman M. G. (2004)

Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder.

Seminars in Pediatric Neurology

11(3), pp. 225-228

Read Abstract (New Window)

Aman M. G. , Turbott S. H. (1991)

Prediction of clinical response in children taking methylphenidate.

Journal of Autism and Developmental Disorders

21(2), pp. 211–228.

Read Abstract (New Window)

Aman M. G. (1982)

Stimulant drug effects in developmental disorders and hyperactivity: toward a resolution of disparate findings.

Journal of Autism and Developmental Disorders

12(4), pp. 385-398

Read Abstract (New Window)

Aman M. G. (1996)

Stimulant drugs in the developmental disabilities revisited.

Journal of Developmental and Physical Disabilities

8(4), pp. 347-365

Read Abstract (New Window)

Aman M. G. , Hollway J. A. , Arnold L. E. (2008)

Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders.

Child and Adolescent Psychiatric Clinics of North America

17(4), pp. 713-738

Read Abstract (New Window)

Anagnostou E. , Hansen R. L. (2011)

Medical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medications.

Current Opinions in Pediatrics

23(6), pp. 621-627.

Read Abstract (New Window)

Bachmann C. J. et al. (2013)

Psychopharmacological treatment in children and adolescents with autism spectrum disorders in Germany.

Research in Developmental Disabilities

June, 34(9), pp. 2551-2563.

Read Abstract (New Window)

Barnard-Brak L. et al. (2016)

Effects associated with on- and off-label stimulant treatment of core autism and ADHD symptoms exhibited by children with autism spectrum disorder.

Developmental Neurorehabilitation

February, 19(1), pp. 46-53.

Read Abstract (New Window)

Birmaher B. , Quintana H. , Greenhill L. L. (1988)

Brief report: Methylphenidate treatment of hyperactive autistic children.

Journal of the American Academy of Child and Adolescent Psychiatry

27(2), pp. 248-251

Read Abstract (New Window)

Campbell M. et al. (1976)

Levodopa and levoamphetamine: a crossover study in young schizophrenic children.

Current Therapeutic Research

19(1), pp. 70-86

Campbell M. et al. (1972)

Response to triiodothyronine and dextroamphetamine: A study of preschool schizophrenic children.

Journal of Autism and Developmental Disorders

2(4),

Read Abstract (New Window)

Canitano R. , Scandurra V. (2011)

Psychopharmacology in autism: An update.

Progress in Neuro-Psychopharmacology and Biological Psychiatry

35(1), pp. 18-28.

Read Abstract (New Window)

Cortese S. et al. (2012)

Psychostimulants for ADHD-like symptoms in individuals with autism spectrum disorders.

Expert Review of Neurotherapeutics

12(4), pp. 461-473.

Read Abstract (New Window) Read Full (New Window)

Coury D. (2011)

Review: little evidence of clear benefit for most medical treatments for children with autism spectrum disorders.

Evidence Based Mental Health

May, 127(5),

Read Abstract (New Window) Read Full (New Window)

Coury D. et al. (2012)

Use of psychotropic medication in children and adolescents with autism spectrum disorders.

Pediatrics

130 S69-76.

Read Abstract (New Window) Read Extract (New Window)

Davis N. O. , Kollins S. (2012)

Treatment for co-occurring attention deficit-hyperactivity disorder and autism spectrum disorder.

Neurotherapeutics

July, 9(3), pp. 518-530.

Read Abstract (New Window) Read Full (New Window)

DiMartino A. et al. (2004)

Methylphenidate for pervasive developmental disorders: safety and efficacy of acute single dose test and ongoing therapy: an open-pilot study.

Journal of Child and Adolescent Psychopharmacology

14(2), pp. 207-218

Read Abstract (New Window)